{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:40:08Z","timestamp":1792834808692,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.resinv.2026.101508","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:08:04Z","timestamp":1788520084000},"page":"101508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R\/E709K-mutated non-small cell lung cancer: A case report"],"prefix":"10.1016","volume":"64","author":[{"given":"Yuto","family":"Tagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Katakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4388-4814","authenticated-orcid":false,"given":"Tetsuro","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-5493","authenticated-orcid":false,"given":"Shuji","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101508_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2014.104","article-title":"Acquired resistance to TKIs in solid tumours: learning from lung cancer","author":"Camidge","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.resinv.2026.101508_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101508_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","author":"Leonetti","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.resinv.2026.101508_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jjco\/hyad052","article-title":"Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance","author":"Araki","year":"2023","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.resinv.2026.101508_bib8","article-title":"Overcoming resistance to osimertinib by T790M loss and C797S acquisition using gefitinib in a patient with EGFR-mutant NSCLC: a case report","author":"Enrico","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.resinv.2026.101508_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cllc.2024.06.003","article-title":"Gefitinib resensitization after a TKI-free interval in osimertinib resistant non-small-cell lung cancer: a glimpse of hope in time of crisis?","author":"Muscolino","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.resinv.2026.101508_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cllc.2023.07.003","article-title":"Tracking clonal evolution of EGFR-mutated non-small cell lung cancer through liquid biopsy: management of C797S acquired mutation","author":"Russo","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.resinv.2026.101508_bib5","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1158\/1078-0432.CCR-15-1046","article-title":"EGFR exon 18 mutations in lung cancer: molecular predictors of augmented sensitivity to afatinib or neratinib as compared with first- or third-generation TKIs","author":"Kobayashi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.resinv.2026.101508_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s13691-023-00653-3","article-title":"EGFR-mutated lung adenocarcinoma with choroidal oligometastasis during treatment with gefitinib: a case report","author":"Hashimoto","year":"2024","journal-title":"Int Cancer Conf J"},{"key":"10.1016\/j.resinv.2026.101508_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jtho.2018.01.009","article-title":"EGFR T790M and C797S mutations as mechanisms of acquired resistance to dacomitinib","author":"Kobayashi","year":"2018","journal-title":"J Thorac Oncol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:29:32Z","timestamp":1792834172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2212534526001425"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101508","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R\/E709K-mutated non-small cell lung cancer: A case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101508"}}